Andromeda Surgical
Andromeda Surgical develops autonomous surgical robots combining anatomical mapping and surgeon oversight, initially for prostate enucleation.
$15MSeries A
ParticipantActivity from announced rounds
Zeno Partners is the investor identified by Andromeda Surgical and confirmed through its own company portfolio.
Andromeda develops surgical robotics with anatomical mapping and surgeon oversight. Zeno Ventures remains a separately named venture arm rather than receiving parent-level participation automatically.
Andromeda Surgical develops autonomous surgical robots combining anatomical mapping and surgeon oversight, initially for prostate enucleation.